Skip to main content
. 2008 Aug 5;99(4):591–596. doi: 10.1038/sj.bjc.6604522

Figure 5.

Figure 5

Percentage change in tumour marker level from baseline to post-treatment. Analysis limited to patients who completed a full course. CEA, carcinoembryonic antigen (normal range <3 μg l−1); CA125, cancer antigen 125 (normal range <30 U ml−1); CA19-9, cancer antigen (normal range <31 U ml−1).